These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

699 related items for PubMed ID: 11126357

  • 1. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
    Huang L, Sowa Y, Sakai T, Pardee AB.
    Oncogene; 2000 Nov 23; 19(50):5712-9. PubMed ID: 11126357
    [Abstract] [Full Text] [Related]

  • 2. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor.
    Sowa Y, Orita T, Minamikawa-Hiranabe S, Mizuno T, Nomura H, Sakai T.
    Cancer Res; 1999 Sep 01; 59(17):4266-70. PubMed ID: 10485470
    [Abstract] [Full Text] [Related]

  • 3. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
    Sowa Y, Orita T, Minamikawa S, Nakano K, Mizuno T, Nomura H, Sakai T.
    Biochem Biophys Res Commun; 1997 Dec 08; 241(1):142-50. PubMed ID: 9405248
    [Abstract] [Full Text] [Related]

  • 4. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T, Matsuzaki Y, Miyazawa K, Zindy F, Roussel MF, Sakai T.
    Oncogene; 2004 Jul 08; 23(31):5340-9. PubMed ID: 15107822
    [Abstract] [Full Text] [Related]

  • 5. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells.
    Xiao H, Hasegawa T, Isobe K.
    J Cell Biochem; 1999 Jun 01; 73(3):291-302. PubMed ID: 10321829
    [Abstract] [Full Text] [Related]

  • 6. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells.
    Lee TH, Chuang LY, Hung WC.
    Oncogene; 2000 Aug 03; 19(33):3766-73. PubMed ID: 10949931
    [Abstract] [Full Text] [Related]

  • 7. Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.
    Zelko IN, Folz RJ.
    Free Radic Biol Med; 2004 Oct 15; 37(8):1256-71. PubMed ID: 15451065
    [Abstract] [Full Text] [Related]

  • 8. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
    Li H, Wu X.
    Biochem Biophys Res Commun; 2004 Nov 12; 324(2):860-7. PubMed ID: 15474507
    [Abstract] [Full Text] [Related]

  • 9. Increased expression of integrin beta1 subunit enhances p21WAF1/Cip1 transcription through the Sp1 sites and p300-mediated histone acetylation in human hepatocellular carcinoma cells.
    Fang Z, Fu Y, Liang Y, Li Z, Zhang W, Jin J, Yang Y, Zha X.
    J Cell Biochem; 2007 Jun 01; 101(3):654-64. PubMed ID: 17211849
    [Abstract] [Full Text] [Related]

  • 10. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
    Lou Z, Maher VM, McCormick JJ.
    Gene; 2005 May 23; 351():51-9. PubMed ID: 15857802
    [Abstract] [Full Text] [Related]

  • 11. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S, Venkatasubbarao K, Li S, Freeman JW.
    Cancer Res; 2003 May 15; 63(10):2624-30. PubMed ID: 12750289
    [Abstract] [Full Text] [Related]

  • 12. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.
    Periyasamy S, Ammanamanchi S, Tillekeratne MP, Brattain MG.
    Oncogene; 2000 Sep 21; 19(40):4660-7. PubMed ID: 11030155
    [Abstract] [Full Text] [Related]

  • 13. HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism.
    Mottet D, Pirotte S, Lamour V, Hagedorn M, Javerzat S, Bikfalvi A, Bellahcène A, Verdin E, Castronovo V.
    Oncogene; 2009 Jan 15; 28(2):243-56. PubMed ID: 18850004
    [Abstract] [Full Text] [Related]

  • 14. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY, Chan JY, Lin HC, Wang SL, Liu ST, Ho CL, Chang LC, Huang SM.
    Mol Cancer Res; 2008 Jul 15; 6(7):1204-14. PubMed ID: 18644983
    [Abstract] [Full Text] [Related]

  • 15. Transcriptional repression of p21((Waf1/Cip1/Sdi1)) gene by c-jun through Sp1 site.
    Wang CH, Tsao YP, Chen HJ, Chen HL, Wang HW, Chen SL.
    Biochem Biophys Res Commun; 2000 Apr 02; 270(1):303-10. PubMed ID: 10733944
    [Abstract] [Full Text] [Related]

  • 16. Expression of cyclin D3 through Sp1 sites by histone deacetylase inhibitors is mediated with protein kinase C-delta (PKC-delta) signal pathway.
    Kim YH, Lim JH, Lee TJ, Park JW, Kwon TK.
    J Cell Biochem; 2007 Jul 01; 101(4):987-95. PubMed ID: 17407153
    [Abstract] [Full Text] [Related]

  • 17. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
    Chao CH, Chen CM, Cheng PL, Shih JW, Tsou AP, Lee YH.
    Cancer Res; 2006 Jul 01; 66(13):6579-88. PubMed ID: 16818630
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.